Ubs Group AG Schedule 13G passive stakes
NYSE
UBS
Ubs Group AGSCHEDULE 13G/A: Norges Bank Discloses 4.0% Passive Stake in UBS Group AG
Norges Bank, acting on behalf of the Government of Norway, has filed an amended Schedule 13G disclosing a 4.0% passive beneficial ownership stake in UBS Group AG as of March 31, 2025.
NYSE
UBS
Ubs Group AGSCHEDULE 13G/A: UBS Group AG Discloses 18.3% Stake in Vipshop Holdings Ltd
UBS Group AG has filed an amended Schedule 13G, revealing a beneficial ownership of 18.3% of Vipshop Holdings Ltd's Class A ordinary shares, totaling 15,943,270 shares, as of December 31, 2024.
NYSE
UBS
Ubs Group AGSCHEDULE 13G/A: UBS Group AG Discloses 5.05% Stake in PIMCO Access Income Fund
UBS Group AG has filed an amended Schedule 13G, reporting a beneficial ownership of 5.05% in PIMCO Access Income Fund's Common Stock as of December 31, 2024.
NYSE
UBS
Ubs Group AGSCHEDULE 13G: UBS Group AG Discloses 5.06% Stake in Renalytix plc Following Credit Suisse Acquisition
UBS Group AG has disclosed a 5.06% beneficial ownership stake in Renalytix plc, holding 16,774,708 ordinary shares, primarily due to its acquisition of Credit Suisse Group AG.
NYSE
UBS
Ubs Group AGSCHEDULE 13G/A: UBS Group AG Amends Liberty Broadband Stake to Zero Following Credit Suisse Acquisition
UBS Group AG has filed an amended Schedule 13G, reporting 0% beneficial ownership in Liberty Broadband Corp's Series C common stock following its acquisition of Credit Suisse Group AG.
NYSE
UBS
Ubs Group AGSCHEDULE 13G/A: UBS Group AG Files Amended Schedule 13G for Amneal Pharmaceuticals, Disclosing Zero Beneficial Ownership
UBS Group AG has filed an amended Schedule 13G for Amneal Pharmaceuticals, Inc., reporting zero beneficial ownership of Class A Common Stock as of December 31, 2024, following its acquisition of Credit Suisse Group AG.
NYSE
UBS
Ubs Group AGUBS Group AG has filed a Schedule 13G, revealing a 7.09% beneficial ownership stake in Color Star Technology Co., Ltd.'s Class A Ordinary Shares as of December 31, 2024.